ST. PAUL, MN -- (MARKET WIRE) -- February 06, 2007 -- elStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, is pleased to announce that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent covering the use of its proprietary over-the-counter product, GelStat™ Migraine, to treat migraine headaches.
